Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of nortriptyline in treating obstructive sleep apnea
IRCT20240407061441N1Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of nortriptyline in obstructive sleep apnea hypopnea syndrome (OSAHS), sponsored by Shahid Beheshti University of Medical Sciences. Started Apr 2024; status: completed.
02
Drugs
nortriptyline
03
Conditions
obstructive sleep apnea hypopnea syndrome (OSAHS)
Beyond the preview
Go deeper on IRCT20240407061441N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240407061441N1.